Idaho Lawmakers Push Bill to Classify Kratom as Schedule I Controlled Substance, Threatening State's Market

Idaho Lawmakers Push Bill to Classify Kratom as Schedule I Controlled Substance, Threatening State's Market

BOISE, ID – March 12, 2026 – Idaho's kratom industry and consumers face a significant threat as state lawmakers have introduced House Bill 864 (HB 864), a legislative measure aimed at classifying kratom as a Schedule I controlled substance. This move, if successful, would effectively ban the sale, possession, and use of all forms of kratom within the state.

The bill, printed and referred to the House's Health and Welfare committee on March 10, 2026, seeks to amend Idaho's Uniform Controlled Substance Act. It specifically targets "alkaloids found or derived from Mitragyna Speciosa" – the botanical name for kratom – by adding them to the state's most restrictive Schedule I list, a category that includes substances like fentanyl. This initiative follows a separate, more regulatory-focused bill (Senate Bill 1282, a Kratom Consumer Protection Act-style measure) that recently stalled in the Senate Agricultural Committee, highlighting a clear division in legislative approaches to kratom in Idaho.

Why This Matters for Kratom Merchants and Consumers

For kratom merchants currently operating in or shipping to Idaho, the implications of HB 864 are severe. Currently, kratom is unregulated in the state, allowing for its legal sale and use. Should HB 864 pass, any commercial activity involving kratom would become illegal, leading to an immediate cessation of business operations in Idaho. Penalties proposed in the bill are stringent, with manufacturing, delivering, or possessing with intent to do so being a felony, punishable by up to five years imprisonment, a $15,000 fine, or both. Simple possession could result in a misdemeanor, carrying up to a year in prison and a $1,000 fine.

For consumers, the bill would eliminate access to kratom products and criminalize possession, even for items legally purchased before the law's enactment. This legislative push underscores the volatile regulatory landscape surrounding kratom across the United States, where some states are moving towards regulation while others pursue outright bans.

Compliance Implications and What High-Risk Merchants Need to Know

If HB 864 passes, previous compliance efforts for selling kratom in Idaho would be rendered obsolete due to a complete prohibition. This situation serves as a stark reminder for high-risk merchants that staying informed about evolving state and local laws is paramount.

In environments with uncertain or changing regulations, robust compliance practices become even more critical. High-risk kratom merchants, regardless of their current operational state, must prioritize:

• Certificates of Analysis (COAs): These documents, issued by independent third-party laboratories, are indispensable. A COA provides a detailed report on a kratom product's composition, verifying alkaloid content (mitragynine and 7-hydroxymitragynine) and, crucially, screening for harmful contaminants such as heavy metals (e.g., lead, mercury), pesticides, mold, bacteria (e.g., Salmonella, E. coli), and synthetic substances. COAs are vital for ensuring product safety, confirming quality and potency, and fostering consumer trust. Moreover, payment processors and regulators increasingly demand valid COAs, making them non-negotiable for maintaining business operations and avoiding fines or product seizures.
• Rigorous Lab Testing: Merchants should insist on comprehensive third-party lab testing for every batch of product. This testing should go beyond basic screens to include full panels for heavy metals, microbial contaminants, pesticides, and a detailed alkaloid profile. Reputable vendors make these COAs readily available to consumers, often directly on product pages.
• Regulatory Compliance:
  • Know Your Laws: Continuously monitor and adhere to the specific legal frameworks in all jurisdictions where products are sold or shipped.
  • Accurate Labeling and Packaging: Ensure all product labels accurately reflect contents, provide clear dosage instructions, and include necessary warnings. Adhering to standards like those from the American Kratom Association's (AKA) Good Manufacturing Practices (GMP) program, which includes disclosing alkaloid content and specific disclaimers, builds credibility.
  • Age Restrictions: Strictly enforce age verification for all sales, typically 18 or 21 years old, depending on state law.
  • Quality Control and Traceability: Source products from suppliers who adhere to strict GMPs, ensuring products are free from adulterants. Maintain clear traceability records for all ingredients and finished products.

The situation in Idaho serves as a powerful reminder that proactive and thorough compliance is not merely a best practice but a fundamental necessity for survival in the dynamic kratom industry.